Turtle Creek Wealth Advisors LLC Takes Position in Oracle Corporation $ORCL

Turtle Creek Wealth Advisors LLC acquired a new position in shares of Oracle Corporation (NYSE:ORCL) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 5,116 shares of the enterprise software provider’s stock, valued at approximately $1,119,000.

Several other hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in Oracle by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock worth $22,498,982,000 after buying an additional 3,513,464 shares during the period. Northern Trust Corp raised its stake in Oracle by 0.6% during the 1st quarter. Northern Trust Corp now owns 19,741,423 shares of the enterprise software provider’s stock worth $2,760,048,000 after buying an additional 120,889 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Oracle by 0.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 13,884,524 shares of the enterprise software provider’s stock worth $1,941,195,000 after buying an additional 59,164 shares during the period. Amundi raised its stake in Oracle by 3.3% during the 1st quarter. Amundi now owns 12,736,855 shares of the enterprise software provider’s stock worth $1,749,280,000 after buying an additional 409,691 shares during the period. Finally, Polen Capital Management LLC raised its stake in Oracle by 17.6% during the 1st quarter. Polen Capital Management LLC now owns 12,609,101 shares of the enterprise software provider’s stock worth $1,762,878,000 after buying an additional 1,885,370 shares during the period. Institutional investors and hedge funds own 42.44% of the company’s stock.

Insider Buying and Selling at Oracle

In related news, insider Michael D. Sicilia sold 33,845 shares of Oracle stock in a transaction dated Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the transaction, the insider owned 132,656 shares in the company, valued at approximately $42,603,800.96. This trade represents a 20.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Clayton M. Magouyrk sold 21,241 shares of Oracle stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $297.11, for a total value of $6,310,913.51. Following the transaction, the insider owned 78,000 shares of the company’s stock, valued at $23,174,580. The trade was a 21.40% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 120,769 shares of company stock valued at $36,428,967 in the last three months. Corporate insiders own 40.90% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on ORCL shares. Barclays raised their price objective on Oracle from $221.00 to $281.00 and gave the stock an “overweight” rating in a research note on Monday, September 8th. Cowen reiterated a “buy” rating and set a $375.00 target price on shares of Oracle in a report on Wednesday, September 10th. UBS Group set a $364.00 target price on Oracle in a report on Friday, September 26th. Mizuho increased their target price on Oracle from $300.00 to $350.00 and gave the stock an “outperform” rating in a report on Wednesday, September 10th. Finally, William Blair reiterated an “outperform” rating on shares of Oracle in a report on Monday, September 22nd. Three analysts have rated the stock with a Strong Buy rating, twenty-seven have issued a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $307.00.

Oracle Price Performance

Shares of NYSE ORCL opened at $303.30 on Thursday. The stock has a market capitalization of $864.64 billion, a price-to-earnings ratio of 70.21, a PEG ratio of 3.22 and a beta of 1.53. The business has a 50-day moving average of $269.61 and a 200-day moving average of $213.14. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72.

Oracle (NYSE:ORCL) last announced its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). The company had revenue of $14.93 billion during the quarter, compared to the consensus estimate of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. Oracle’s revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, sell-side analysts predict that Oracle Corporation will post 5 earnings per share for the current fiscal year.

Oracle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 23rd. Investors of record on Thursday, October 9th will be issued a dividend of $0.50 per share. The ex-dividend date is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. Oracle’s dividend payout ratio (DPR) is presently 46.30%.

Oracle Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.